Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01485016 · ClinicalTrials.gov registry record
Physiological and Biomechanical Data Collection Study in Epilepsy Subjects
A clinical trial, sponsored by Cyberonics.
- Completed
- Registry status
- 20
- Enrollment target
NCT01485016: Completed study, sponsored by Cyberonics.
NCT01485016 is a clinical trial that has completed, run by Cyberonics. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01485016 has completed, sponsored by Cyberonics.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to gather changes in physiological and biomechanical data during daily activity and sleep in epilepsy subjects.
Primary Outcome
The E-32 study was designed to capture the subject's physiological and biomechanical data such as ECG data and rate, respiratory data and rate, and body orientation, motion and movement (accelerometry) during typical events such as walking, sitting, running and sleeping in order to help build a database of stereotypical human activity.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-11 |
| Est. Completion | 2012-07 |
What the finished NCT01485016 record still lists
NCT01485016 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01485016 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01485016 about?
NCT01485016 is a clinical study titled "Physiological and Biomechanical Data Collection Study in Epilepsy Subjects". The purpose of this study is to gather changes in physiological and biomechanical data during daily activity and sleep in epilepsy subjects.
What is the current status of trial NCT01485016?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2011-11. Estimated completion is 2012-07.
Who is sponsoring clinical trial NCT01485016?
This trial is sponsored by Cyberonics, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia